A Narrative Review on Disease Models Used in the Study of Inflammatory Bowel Disease

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, is a chronic, relapsing immune-mediated disorder of the gastrointestinal tract. Its pathogenesis involves complex interactions among genetic susceptibility, the intestinal microbiota, environmental factors and dysregulated mucosal immunity. The development and refinement of disease models have been central to mechanistic understanding and therapeutic innovation in IBD. This review provides a comprehensive overview of the major disease models currently employed in IBD research, including chemically induced rodent models (dextran sodium sulfate, trinitrobenzene sulfonic acid and oxazolone), genetic and immune-transfer models (IL-10 knockout, T-cell transfer colitis, MDR1a knockout, SAMP1/YitFc ileitis and Nod2/Nox2 knockout model mice), microbiota-associated models (germ-free, gnotobiotic and human microbiota-associated mice), humanized mouse models, and human-derived in vitro and ex vivo platforms (intestinal organoids, colonoids, explant cultures and organ-on-a-chip). We discuss the mechanistic basis, histopathological features, advantages and limitations of each model in the context of Crohn's disease or ulcerative colitis biology. We further highlight recent advances including patient-derived organoid biobanks, organoid-immune cell co-culture systems, CRISPR-engineered IBD knock-in models, the integration of single-cell and spatial transcriptomics and AI-assisted model prediction. Critical gaps remain, particularly in modeling intestinal fibrosis and accounting for sex as a biological variable. No single model fully recapitulates the multifaceted pathogenesis of human IBD; strategic selection and complementary use of multiple models across biological scales remain essential for translational progress. This review aims to guide researchers in selecting appropriate models and interpreting findings within their biological and translational context.

Authors

Institutions

Publication Details

Journal
Infectious Microbes & Diseases
Published
2026-06-29
DOI
https://doi.org/10.1097/im9.0000000000000214
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Narrative Review on Disease Models Used in the Study of Inflammatory Bowel Disease

Ruo Wang, Yiwen Xie, Cao Hongcui, Chenjie Huang
Infectious Microbes & Diseases
Inflammatory Bowel Disease
article

A Narrative Review on Disease Models Used in the Study of Inflammatory Bowel Disease

Ruo Wang, Yiwen Xie, Cao Hongcui, Chenjie Huang
article en

Abstract

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, is a chronic, relapsing immune-mediated disorder of the gastrointestinal tract. Its pathogenesis involves complex interactions among genetic susceptibility, the intestinal microbiota, environmental factors and dysregulated mucosal immunity. The development and refinement of disease models have been central to mechanistic understanding and therapeutic innovation in IBD. This review provides a comprehensive overview of the major disease models currently employed in IBD research, including chemically induced rodent models (dextran sodium sulfate, trinitrobenzene sulfonic acid and oxazolone), genetic and immune-transfer models (IL-10 knockout, T-cell transfer colitis, MDR1a knockout, SAMP1/YitFc ileitis and Nod2/Nox2 knockout model mice), microbiota-associated models (germ-free, gnotobiotic and human microbiota-associated mice), humanized mouse models, and human-derived in vitro and ex vivo platforms (intestinal organoids, colonoids, explant cultures and organ-on-a-chip). We discuss the mechanistic basis, histopathological features, advantages and limitations of each model in the context of Crohn's disease or ulcerative colitis biology. We further highlight recent advances including patient-derived organoid biobanks, organoid-immune cell co-culture systems, CRISPR-engineered IBD knock-in models, the integration of single-cell and spatial transcriptomics and AI-assisted model prediction. Critical gaps remain, particularly in modeling intestinal fibrosis and accounting for sex as a biological variable. No single model fully recapitulates the multifaceted pathogenesis of human IBD; strategic selection and complementary use of multiple models across biological scales remain essential for translational progress. This review aims to guide researchers in selecting appropriate models and interpreting findings within their biological and translational context.

Infectious Microbes & Diseases
First People's Hospital of Yuhang District (CN), National Center for Infectious Diseases (US)
Industry, innovation and infrastructure
Openalex Percentile: Top 8%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.